logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

David W. Boulton

clinical pharmacology

45H-index
200Paper Count
7.1KCitation Count
Published Papers 93
Publication Date
logo
Eosinophilic Depletion with Benralizumab; Mepolizumab; and Depemokimab: A Modeling Study
errJournal of Asthma and Allergy
IF3
err2026-05-19
err0
errOAAI
errPradeep B Lukka; Robert C Penland; Ari Brekkan; Rami Ayoun Alsoud; Sherri So; David W Boulton
errShare
errSave
Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration
errClinical Pharmacology & Therapeutics
IF5.5
err2024-12-14
err0
errOAAI
errJin Dong; Pradeep Sharma; Rasha Emara; Derek Cheung; Weifeng Tang; Diansong Zhou; David W. Boulton; Mats Någård; Miki S. Park
errShare
errSave
Physiology-based pharmacokinetic model with relative transcriptomics to evaluate tissue distribution and receptor occupancy of anifrolumab
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2024-10-03
err1
errOAAI
errSharma, Pradeep; Boulton, David W.; Bertagnolli, Lynn N.; Tang, Weifeng
errShare
errSave
Racial Comparison of the Pharmacokinetics and Safety of Fixed-dose Combination of Dapagliflozin/Sitagliptin in Western and Korean Healthy Adults
errCLINICAL THERAPEUTICS
IF3.6
err2024-09-01
err0
PREAI
errLukka, Pradeep B.; Tang, Weifeng; Hammarstedt, Ann; Conrad, Tom; Heijer, Maria; Karlsson, Cecilia; Boulton, David W.
errShare
errSave
The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial
errBRITISH JOURNAL OF PHARMACOLOGY
IF7.7
err2024-08-19
err1
errOAAI
errYu, Hongtao; Greasley, Peter J.; Heerspink, Hiddo J. Lambers; Ambery, Philip; Ahlstrom, Christine; Hamren, Bengt; Khan, Anis A.; Boulton, David W.; Hallow, K. Melissa
errShare
errSave
A literature review of drug transport mechanisms during lactation
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2024-07-07
err7
errOAAI
errGong, Christine; Bertagnolli, Lynn N.; Boulton, David W.; Coppola, Paola
errShare
errSave
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2023-12-04
err1
errOAAI
errClegg, Lindsay E.; Chu, Lulu; Nagard, Mats; Boulton, David W.; Penland, Robert C.
errShare
errSave
A systematic review of pregnancy-related clinical intervention of drug regimens due to pharmacokinetic reasons
errFRONTIERS IN MEDICINE
IF3
err2023-11-29
err3
errOAAI
errBorda, Lauren A.; Nagard, Mats; Boulton, David W.; Venkataramanan, Raman; Coppola, Paola
errShare
errSave
Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2023-11-20
err0
PREAI
errMelin, Johanna; Parkinson, Joanna; Hamren, Bengt; Penland, Robert C.; Boulton, David W.; Tang, Weifeng
errShare
errSave
A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy
errPHARMACEUTICS
IF5.5
err2023-11-15
err6
errOAAI
errGong, Christine; Bertagnolli, Lynn N.; Boulton, David W.; Coppola, Paola
errShare
errSave
Pharmacokinetic Variables of Dapagliflozin/Metformin Extended-release Fixed-dose Combination in Healthy Chinese Volunteers and Regional Comparison
errCLINICAL THERAPEUTICS
IF3.6
err2023-08-01
err2
errOAAI
errZhao, Xiaoying; Ning, Rui; Hui, Andrew; Boulton, David W.; Tang, Weifeng
errShare
errSave
Application of population physiologically based pharmacokinetic modelling to optimize target expression and clearance mechanisms of therapeutic monoclonal antibodies
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2023-05-01
err2
PREAI
errReig-Lopez, Javier; Tang, Weifeng; Fernandez-Teruel, Carlos; Merino-Sanjuan, Matilde; Mangas-Sanjuan, Victor; Boulton, David W.; Sharma, Pradeep
errShare
errSave
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2023-03-16
err1
errOAAI
errSokolov, Victor; Yakovleva, Tatiana; Stolbov, Leonid; Penland, Robert C.; Boulton, David; Parkinson, Joanna; Tang, Weifeng
errShare
errSave
Therapeutic Protein Drug Interactions: A White Paper From the International Consortium for Innovation and Quality in Pharmaceutical Development
errCLINICAL PHARMACOLOGY & THERAPEUTICS
IF5.5
err2023-01-17
err10
errOAAI
errCoutant, David E.; Boulton, David W.; Dahal, Upendra P.; Deslandes, Antoine; Grimaldi, Christine; Pereira, Joao N. S.; Saell, Carolina; Sarvaiya, Hetal; Schiller, Hilmar; Tai, Guoying; Umehara, Kenichi; Yuan, Yang; Dallas, Shannon
errShare
errSave
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF
errEUROPEAN JOURNAL OF HEART FAILURE
IF10.8
err2022-08-22
err17
errOAAI
errAdamson, Carly; Cowan, Lorna M.; de Boer, Rudolf A.; Diez, Mirta; Drozdz, Jaroslaw; Dukat, Andre; Inzucchi, Silvio E.; Kober, Lars; Kosiborod, Mikhail N.; Ljungman, Charlotta E. A.; Martinez, Felipe A.; Ponikowski, Piotr; Sabatine, Marc S.; Lindholm, Daniel; Bengtsson, Olof; Boulton, David W.; Greasley, Peter J.; Langkilde, Anna Maria; Sjostrand, Mikaela; Solomon, Scott D.; McMurray, John J., V; Jhund, Pardeep S.
errShare
errSave
Common UGT1A9 polymorphisms do not have a clinically meaningful impact on the apparent oral clearance of dapagliflozin in type 2 diabetes mellitus
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2022-01-23
err9
errOAAI
errNaagaard, M. Daniel; Chang, Roy; Nagard, Mats; Tang, Weifeng; Boulton, David W.
errShare
errSave
Evolving drug regulatory landscape in China: A clinical pharmacology perspective
errCTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
err2021-02-23
err19
errOAAI
errTang, Weifeng; Huang, Ying; Zhou, Diansong; Huang, Yao; Chen, Yingxue; Ren, Song; Li, Yan; Wu, Shengqian; Zhao, Xiaoying; Song, Xuyang; Wang, Haidong; Jin, Yuwen; Yu, Hongtao; Zhang, Li; Li, Yunfei; Boulton, David; Shen, Kevin
errShare
errSave
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials
errDIABETES OBESITY & METABOLISM
IF5.7
err2021-02-02
err6
PREAI
errClegg, Lindsay E.; Jing, Yankang; Penland, Robert C.; Boulton, David W.; Hernandez, Adrian F.; Holman, Rury R.; Vora, Jiten
errShare
errSave
A model-based approach to investigating the relationship between glucose-insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2021-01-25
err6
PREAI
errShah, Millie; Stolbov, Leonid; Yakovleva, Tatiana; Tang, Weifeng; Sokolov, Victor; Penland, Robert C.; Boulton, David; Parkinson, Joanna
errShare
errSave
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes
errCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY
IF3
err2021-01-13
err17
errOAAI
errJo, Heeseung; Pilla Reddy, Venkatesh; Parkinson, Joanna; Boulton, David W.; Tang, Weifeng
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
J
John J.V. McMurray
H-index: 231 · Papers: 2.6K
S
Scott D. Solomon
H-index: 188 · Papers: 2.0K
P
Piotr Ponikowski
H-index: 179 · Papers: 1.4K
M
Michael Böhm
H-index: 164 · Papers: 1.8K
L
Lars Køber
H-index: 155 · Papers: 2.1K
View more